These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 22024080)

  • 1. Plasma fibrinogen-like protein 2 levels in patients with non-alcoholic fatty liver disease.
    Colak Y; Senates E; Ozturk O; Yilmaz Y; Coskunpinar E; Kahraman OT; Sahin O; Zemheri E; Enc FY; Ulasoglu C; Kiziltas S; Kurdas OO; Tuncer I
    Hepatogastroenterology; 2011; 58(112):2087-90. PubMed ID: 22024080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical and histological features of non-alcoholic fatty liver disease].
    Shi JP; Xun YH; Hu CB; Zhang L; Liu H; Lou GQ; Fan JG
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):812-6. PubMed ID: 19958638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease.
    Lemoine M; Ratziu V; Kim M; Maachi M; Wendum D; Paye F; Bastard JP; Poupon R; Housset C; Capeau J; Serfaty L
    Liver Int; 2009 Oct; 29(9):1431-8. PubMed ID: 19422483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum concentrations of human insulin-like growth factor-1 and levels of insulin-like growth factor-binding protein-5 in patients with nonalcoholic fatty liver disease: association with liver histology.
    Colak Y; Senates E; Ozturk O; Yilmaz Y; Zemheri E; Yilmaz Enc F; Ulasoglu C; Aksaray S; Bozbeyoglu SG; Kiziltas S; Kurdas OO; Tuncer I
    Eur J Gastroenterol Hepatol; 2012 Mar; 24(3):255-61. PubMed ID: 22157234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease.
    Coulon S; Francque S; Colle I; Verrijken A; Blomme B; Heindryckx F; De Munter S; Prawitt J; Caron S; Staels B; Van Vlierberghe H; Van Gaal L; Geerts A
    Cytokine; 2012 Aug; 59(2):442-9. PubMed ID: 22658783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years.
    Wong VW; Wong GL; Choi PC; Chan AW; Li MK; Chan HY; Chim AM; Yu J; Sung JJ; Chan HL
    Gut; 2010 Jul; 59(7):969-74. PubMed ID: 20581244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The novel immunoregulatory molecule FGL2: a potential biomarker for severity of chronic hepatitis C virus infection.
    Foerster K; Helmy A; Zhu Y; Khattar R; Adeyi OA; Wong KM; Shalev I; Clark DA; Wong PY; Heathcote EJ; Phillips MJ; Grant DR; Renner EL; Levy GA; Selzner N
    J Hepatol; 2010 Oct; 53(4):608-15. PubMed ID: 20615566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
    Ito S; Yukawa T; Uetake S; Yamauchi M
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease.
    Haukeland JW; Konopski Z; Linnestad P; Azimy S; Marit Løberg E; Haaland T; Birkeland K; Bjøro K
    Scand J Gastroenterol; 2005 Dec; 40(12):1469-77. PubMed ID: 16293559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated plasma homocysteine concentrations as a predictor of steatohepatitis in patients with non-alcoholic fatty liver disease.
    Gulsen M; Yesilova Z; Bagci S; Uygun A; Ozcan A; Ercin CN; Erdil A; Sanisoglu SY; Cakir E; Ates Y; Erbil MK; Karaeren N; Dagalp K
    J Gastroenterol Hepatol; 2005 Sep; 20(9):1448-55. PubMed ID: 16105135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of hepcidin in patients with biopsy-proven nonalcoholic fatty liver disease.
    Senates E; Yilmaz Y; Colak Y; Ozturk O; Altunoz ME; Kurt R; Ozkara S; Aksaray S; Tuncer I; Ovunc AO
    Metab Syndr Relat Disord; 2011 Aug; 9(4):287-90. PubMed ID: 21417913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of serum hyaluronic acid, TNF-alpha and IL-8 in patients with nonalcoholic steatohepatitis.
    Bahcecioglu IH; Yalniz M; Ataseven H; Ilhan N; Ozercan IH; Seckin D; Sahin K
    Hepatogastroenterology; 2005; 52(65):1549-53. PubMed ID: 16201116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum concentrations of human angiopoietin-like protein 3 in patients with nonalcoholic fatty liver disease: association with insulin resistance.
    Yilmaz Y; Ulukaya E; Atug O; Dolar E
    Eur J Gastroenterol Hepatol; 2009 Nov; 21(11):1247-51. PubMed ID: 19474742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of vaspin, obestatin, and apelin-36 in patients with nonalcoholic fatty liver disease.
    Aktas B; Yilmaz Y; Eren F; Yonal O; Kurt R; Alahdab YO; Celikel CA; Ozdogan O; Imeryuz N; Kalayci C; Avsar E
    Metabolism; 2011 Apr; 60(4):544-9. PubMed ID: 20580037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.
    Weiner RA
    Dig Dis; 2010; 28(1):274-9. PubMed ID: 20460923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.
    Miquilena-Colina ME; Lima-Cabello E; Sánchez-Campos S; García-Mediavilla MV; Fernández-Bermejo M; Lozano-Rodríguez T; Vargas-Castrillón J; Buqué X; Ochoa B; Aspichueta P; González-Gallego J; García-Monzón C
    Gut; 2011 Oct; 60(10):1394-402. PubMed ID: 21270117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum fetuin A/α2HS-glycoprotein levels in patients with non-alcoholic fatty liver disease: relation with liver fibrosis.
    Yilmaz Y; Yonal O; Kurt R; Ari F; Oral AY; Celikel CA; Korkmaz S; Ulukaya E; Ozdogan O; Imeryuz N; Avsar E; Kalayci C
    Ann Clin Biochem; 2010 Nov; 47(Pt 6):549-53. PubMed ID: 20926473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptin levels in nonalcoholic steatohepatitis and chronic hepatitis C.
    Giannini E; Botta F; Cataldi A; Tenconi GL; Ceppa P; Barreca T; Testa R
    Hepatogastroenterology; 1999; 46(28):2422-5. PubMed ID: 10522010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silent non-alcoholic fatty liver disease-a clinical-histological study.
    Sorrentino P; Tarantino G; Conca P; Perrella A; Terracciano ML; Vecchione R; Gargiulo G; Gennarelli N; Lobello R
    J Hepatol; 2004 Nov; 41(5):751-7. PubMed ID: 15519647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of serum lipoprotein-associated phospholipase A2 level with nonalcoholic fatty liver disease.
    Colak Y; Senates E; Ozturk O; Doganay HL; Coskunpinar E; Oltulu YM; Eren A; Sahin O; Ozkanli S; Enc FY; Ulasoglu C; Tuncer I
    Metab Syndr Relat Disord; 2012 Apr; 10(2):103-9. PubMed ID: 22112193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.